The CU Healthcare Innovation Fund
VC Fund
Aurora, United States
The CU Healthcare Innovation Fund is a VC fund in Aurora focused on Health Care and Medical. The CU Healthcare Innovation Fund is located on the University of Colorado Anschutz Medical Campus in Aurora, Colorado. The fund invests in companies that have developed meaningful partnerships with the institutions on the campus. The $50 million fund invests across digital health, therapeutics and devices.
- Total investments:
- 31
- Last investment:
- Lead investor:
- 6%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries The CU Healthcare Innovation Fund invests in
Stages The CU Healthcare Innovation Fund invests in
Countries The CU Healthcare Innovation Fund invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Investment Focus
Industry
- Health Care 19 (61%)
- Medical 9 (29%)
- Biotechnology 6 (19%)
- Medical Device 6 (19%)
- Hospital 4 (13%)
Stage
- Series A 12 (39%)
- Series B 6 (19%)
- Funding Round 3 (10%)
- Venture - Series Unknown 3 (10%)
- Seed 1 (3%)
Country
- United States 21 (68%)
- Canada 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Gali Baler
Director of Investments
|
Director of Investments | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
410 Medical
|
410 Medical has developed a simple, intuitive solution that allows a single healthcare provider to rapidly deliver fluid to critically ill patients, improving care, and saving lives. Their device allows fast set-up, improves resuscitation speed, minimizes provider fatigue, and frees providers to address other patient care issues simultaneously.This solution is particularly useful in pre-hospital settings and the emergency department and where speed is critical and resources may be limited.It was founded in 2013 and headquartered in Durham, North Carolina. | $12M / Venture - Series Unknown / Jul 14, 2026 | |
Icarus Medical Innovations
|
Icarus Medical Innovations specializes in the design and manufacture of custom knee braces to treat osteoarthritis. | $7.2M / Series A / Jun 17, 2026 | |
Monteris Medical
|
Monteris Medical is a medical device venture that develops new technologies for the treatment of cancer. It is a private equity-backed neurosurgical company focused solely on diseases of the brain. It develops MRI-guided, laser-based systems designed for the ablation of brain lesions. The company's system applies focused laser energy to ablatebrain tumors from the inside, with little or no effect on surrounding healthy tissue as well as provides clinicians a new neurosurgical tool that offers real-time control and visualization of the therapy during laser ablation treatment, enabling neurosurgeons to ablate (treat with lethal heat) brain lesions and brain tumors that may be difficult to approach via traditional methods.It was founded in 1999 and has offices in Minneapolis, Minnesota, USA and Winnipeg, Manitoba, Canada. | $28M / Series E / Mar 12, 2026 | |
Arbutus Medical
|
Every hospital in the world is faced with a major challenge - the rising cost of heathcare - we want to do something about it. Arbutus Medical’s purpose is to develop a portfolio of “frugal innovation” devices that save costs for hospitals and improve access to orthopedic surgery for 5 million patients by 2030. Arbutus Medical's flagshipproduct is a radically affordable orthopaedic power tool system that is used in North American Trauma Centers, veterinary hospitals, military deployments, NGO missions, and hospitals in over 30 low- and middle-income countries worldwide. | $6.8M / Feb 17, 2026 | |
Think Bioscience
|
Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems. | $55M / Series A / Jan 20, 2026 | |
Carta Healthcare
|
Carta empowers hospitals to personalize the delivery of care to the individual needs of each patient. The approach Carta Healthcare is advocating and enabling is to: find past patients similar to the current one being treated; quantify what exactly happened to them during their journey through the hospital (this is where our model comes in) and;use machine learning to project what the particular patient in question will need, and what the patient can expect their experience to be in the hospital. Carta was founded in 2017 and is based in Palo Alto, California, United States. | $18.3M / Series B / May 07, 2025 | |
|
410 Medical
|
410 Medical has developed a simple, intuitive solution that allows a single healthcare provider to rapidly deliver fluid to critically ill patients, improving care, and saving lives. Their device allows fast set-up, improves resuscitation speed, minimizes provider fatigue, and frees providers to address other patient care issues simultaneously.This solution is particularly useful in pre-hospital settings and the emergency department and where speed is critical and resources may be limited.It was founded in 2013 and headquartered in Durham, North Carolina. | $14M / Series B / Mar 17, 2025 | |
Jupiter BioVentures
|
Jupiter BioVentures is a creation engine company that focuses on de-risking early-stage projects. | $70M / Venture - Series Unknown / Nov 19, 2024 | |
Foresight Diagnostics
|
Foresight Diagnostics develops novel technology created to detect cancers earlier from a simple blood draw. | $33M / Series B / Jul 30, 2024 | |
Clarapath
|
Clarapath is a medical robotics company automating the laboratory. The company's first product is focused on fully automating the microtomy station in pathology. Their vision is to innovate, standardize, and digitally transform anatomic pathology through higher-quality lab medicine, more robust safety standards, and increased lab throughputwhile lowering laboratory costs and labor-related delays.Their next-generation laboratory at the NY Genome Center together with our large-scale image repository and analysis platform are designed to handle the entire “tissue to bits” pipeline for special research projects as well as larger-scale clinical needs. Clarapath works closely with both research and clinical customers to produce faster, more accurate results. | $36M / Series B / Jul 24, 2024 | |
| See all 31 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does The CU Healthcare Innovation Fund invest in?
The CU Healthcare Innovation Fund invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Series B stage. Most of the 31 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact The CU Healthcare Innovation Fund?
Public channels for The CU Healthcare Innovation Fund include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at The CU Healthcare Innovation Fund?
The team at The CU Healthcare Innovation Fund includes Gali Baler (Director of Investments). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
